Skip to main content

Quality and Safety

By Jeff Lagasse | 02:54 pm | May 15, 2020
Hydroxychloroquine can reduce inflammation, pain and swelling, but mild to moderate COVID patients showed more adverse events when treated with it.
By Susan Morse | 09:21 am | May 14, 2020
America's Health Insurance Plans is also promoting the continued widespread adoption and use of telemedicine.
By Susan Morse | 07:44 am | May 14, 2020
Phases 2 and 3 of vaccine clinical trials are expected by early summer and their success will be known by early winter, Fauci says.
By Jeff Lagasse | 03:21 pm | May 12, 2020
In addition to an expanded ED, the hospital knew it had to improve interstaff communications to bolster patient care.
By Susan Morse | 02:26 pm | May 12, 2020
By the end of March, 33% of behavioral health claims for Optum members were for a telehealth visit, compared to 2% prior to COVID-19.
By Jeff Lagasse | 10:13 am | May 12, 2020
The action is meant to enable GE to overcome supply chain disruptions as it addresses the surge in demand for critical equipment.
By Jeff Lagasse | 02:45 pm | May 11, 2020
Some stroke patients may fear contracting the coronavirus, while others who are isolated may not be discovered quickly enough.
By Jeff Lagasse | 12:04 pm | May 11, 2020
The treatment may reduce the risk to healthcare workers because it reduces the duration and quantity of viral shedding.
By Susan Morse | 02:30 pm | May 09, 2020
Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.
By Jeff Lagasse | 11:37 am | May 08, 2020
The test could detect COVID-19 infections in about six out of 10 people, and was nearly perfect in determining when an infection wasn't present.